TY  - JOUR

T1  - EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE). A cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome

JO  - American Heart Journal

PY  - 2011/01/01

AU  - White WB

AU  - Bakris GL

AU  - Bergenstal RM

AU  - Cannon CP

AU  - Cushman WC

AU  - Fleck P

AU  - Heller S

AU  - Mehta C

AU  - Nissen SE

AU  - Perez A

AU  - Wilson C et al

ED  - 

Y2  - 2024/10/22

ER  -